Kodiak Sciences Inc (KOD): Price and Financial Metrics

Kodiak Sciences Inc (KOD): $7.45

0.35 (+4.93%)

POWR Rating

Component Grades

Momentum

C

Stability

D

Sentiment

Quality

D

Add KOD to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#272 of 363

in industry

KOD Price/Volume Stats

Current price $7.45 52-week high $9.80
Prev. close $7.10 52-week low $1.37
Day low $7.09 Volume 2,883,700
Day high $7.77 Avg. volume 839,595
50-day MA $5.24 Dividend yield N/A
200-day MA $3.83 Market Cap 390.92M

KOD Stock Price Chart Interactive Chart >


Kodiak Sciences Inc (KOD) Company Bio


Kodiak Sciences is a clinical stage biopharma specializing in therapeutics to treat chronic retinal diseases. The company was founded in 2005 and is based in New York City, New York.


KOD Latest News Stream


Event/Time News Detail
Loading, please wait...

KOD Latest Social Stream


Loading social stream, please wait...

View Full KOD Social Stream

Latest KOD News From Around the Web

Below are the latest news stories about KODIAK SCIENCES INC that investors may wish to consider to help them evaluate KOD as an investment opportunity.

Kodiak Sciences Inc. (KOD) Up 43.6% Since Last Earnings Report: Can It Continue?

Kodiak Sciences Inc. (KOD) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Yahoo | December 14, 2023

Kodiak Sciences to Present at the 6th Annual Evercore ISI HealthCONx Conference

Kodiak Sciences Inc. (Nasdaq: KOD), a biopharmaceutical company committed to researching, developing and commercializing transformative therapeutics to treat high prevalence retinal diseases, announced today that management will present at the 6th Annual Evercore ISI HealthCONx Conference in Miami, Florida on Wednesday, November 29, 2023, at 3:25 p.m. Eastern Time (12:25 p.m. Pacific Time).

Yahoo | November 21, 2023

Kodiak (KOD) Beats Q3 Earnings, Provides Pipeline Updates

Kodiak (KOD) reports better-than-expected third-quarter 2023 results and provides updates regarding its pipeline development plans.

Yahoo | November 15, 2023

Kodiak Sciences Inc (KOD) Reports Q3 2023 Financial Results: Net Loss Narrows, R&D Expenses ...

Key Financial Highlights and Pipeline Developments

Yahoo | November 14, 2023

Kodiak Sciences Announces Third Quarter 2023 Financial Results and Recent Business Highlights

Kodiak Sciences Inc. (Nasdaq: KOD), today reported business highlights and financial results for the quarter ended September 30, 2023.

Yahoo | November 14, 2023

Read More 'KOD' Stories Here

KOD Price Returns

1-mo 21.34%
3-mo 145.07%
6-mo 313.89%
1-year 23.34%
3-year -66.96%
5-year 470.44%
YTD 145.07%
2023 -57.54%
2022 -57.77%
2021 -42.29%
2020 104.18%
2019 913.38%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!